Neuronetics STIM Income Statement
| FY'25 | FY'24 | FY'23 | FY'22 | ||
|---|---|---|---|---|---|
| $149.16M+99.2% | $74.89M+5.0% | $71.35M+9.4% | $65.21M+17.9% | ||
| $76.85M+271% | $20.73M+5.5% | $19.64M+26.9% | $15.48M+32.9% | ||
| $72.31M+33.5% | $54.16M+4.8% | $51.71M+4.0% | $49.72M+13.9% | ||
| 48.5%-23.8pp | 72.3%-0.1pp | 72.5%-3.8pp | 76.3%-2.7pp | ||
| $6.58M-48.4% | $12.77M+34.2% | $9.52M+1.9% | $9.34M+17.8% | ||
| $47.46M+4.0% | $45.63M-3.6% | $47.32M-5.3% | $49.98M+32.4% | ||
| $49.7M+63.9% | $30.32M+19.3% | $25.43M-0.4% | $25.52M-0.1% | ||
| $103.74M+16.9% | $88.73M+7.9% | $82.26M-3.0% | $84.83M+19.1% | ||
| -$31.44M+9.1% | -$34.57M-13.1% | -$30.55M+13.0% | -$35.11M-27.4% | ||
| -21.1%+25.1pp | -46.2%-3.3pp | -42.8%+11.0pp | -53.8%-4.0pp | ||
| $8.42M+15.5% | $7.29M+34.3% | $5.43M+27.6% | $4.25M+5.8% | ||
| $716K-71.9% | $2.55M-55.9% | $5.79M+163% | $2.2M+465% | ||
| -$39M+10.8% | -$43.71M-44.8% | -$30.19M+18.8% | -$37.16M-19.1% | ||
| -26.1%+32.2pp | -58.4%-16.1pp | -42.3%+14.7pp | -57%-0.6pp | ||
| -$0.59+57.2% | -$1.38-30.2% | -$1.06+23.2% | -$1.38-16.0% | ||
| -$27.97M+13.9% | -$32.49M-13.8% | -$28.55M+14.7% | -$33.46M-26.3% | ||
| -18.8%+24.6pp | -43.4%-3.4pp | -40%+11.3pp | -51.3%-3.4pp | ||
| -$31.44M+9.1% | -$34.57M-13.1% | -$30.55M+13.0% | -$35.11M-27.4% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- What is Neuronetics's revenue?
- Neuronetics (STIM) generated $151.6M in revenue over the trailing twelve months, up 69.5% year over year.
- Is Neuronetics profitable?
- Neuronetics is not currently profitable: it reported a net loss of $37.1M over the trailing twelve months, a -24.5% net margin.
- What are Neuronetics's profit margins?
- Gross margin is 48.0% and operating margin is -19.4%, with a -24.5% net margin.
- What is Neuronetics's earnings per share?
- Neuronetics's diluted EPS over the trailing twelve months is $-0.54.
- Where does Neuronetics's income statement data come from?
- Every line is extracted from Neuronetics's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.
